Nom du produit:(R,2E,4E)-11-((2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl)-3,5,7-trimethylundeca-2,4-dienoic acid

IUPAC Name:(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

CAS:29066-42-0
Formule moléculaire:C18H28O5
Pureté:97%
Numéro de catalogue:CM200640
Poids moléculaire:324.42

Unité d'emballage Stock disponible Prix($) Quantité
CM200640-10mg 4-5 Weeks NJǵNJǵ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:29066-42-0
Formule moléculaire:C18H28O5
Point de fusion:-
Code SMILES:O=C(O)/C=C(C)/C=C(C)/C[C@H](C)CCCC[C@H]([C@H]1CO)OC1=O
Densité:
Numéro de catalogue:CM200640
Poids moléculaire:324.42
Point d'ébullition:
N° Mdl:MFCD01940046
Stockage:

Category Infos

Oxetanes
Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.